![Yan Ling Cao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yan Ling Cao
Directeur/Membre du Conseil chez
OCUMENSION THERAPEUTICS
Profil
Mr. Yan Ling Cao is a Partner & Member at Boyu Capital Group Management Ltd. He is on the Board of Directors at Gushengtang Holdings Ltd., Ocumension Therapeutics, WuXi Biologics (Cayman), Inc., Life Science Holdings, Inc., LifeMine Therapeutics, Inc., Wuxi Biologics Holdings Ltd., Wuxi New Life Science Investment Ltd., Wuxi Nextcode Holdings Ltd. and Wuxi PharmaTech (Cayman), Inc. Mr. Cao was previously employed as an Independent Non-Executive Director by JW (Cayman) Therapeutics Co. Ltd., a Non-Executive Director by Antengene Corp.
Ltd., a Non-Executive Director by Antengene Corporation Co., Ltd., an Independent Director by Viela Bio, Inc., a Non-Executive Director by Hygeia Healthcare Holdings Co., Ltd., a Non-Executive Director by CStone Pharmaceuticals Co. Ltd., a Senior Investment Manager by General Atlantic LLC (China), and a Senior Investment Analyst by General Atlantic Asia Ltd. He also served on the board at Gan & Lee Pharmaceuticals Co., Ltd., Fujian Herui Gene Technology Co., Ltd. and WuXi AppTec Co., Ltd. He received his undergraduate degree from Middlebury College.
Postes actifs de Yan Ling Cao
| Sociétés | Poste | Début |
|---|---|---|
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Directeur/Membre du Conseil | - |
| WUXI BIOLOGICS (CAYMAN) INC. | Directeur/Membre du Conseil | 01/05/2016 |
| OCUMENSION THERAPEUTICS | Directeur/Membre du Conseil | 18/06/2019 |
| GUSHENGTANG HOLDINGS LIMITED | Directeur/Membre du Conseil | 31/03/2026 |
Boyu Capital Group Management Ltd. | Corporate Officer/Principal | 01/03/2011 |
Life Science Holdings, Inc.
 Life Science Holdings, Inc. Pharmaceuticals: OtherHealth Technology Manufactures white and private label cannabinoid products | Directeur/Membre du Conseil | - |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Directeur/Membre du Conseil | - |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Wuxi Nextcode Holdings Ltd.
 Wuxi Nextcode Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Yan Ling Cao
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Yan Ling Cao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. BiotechnologyHealth Technology Engages in contract research, development and manufacturing organization of chemistry drugs and pharmaceuticals | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WuXi AppTec Co., Ltd.
 WuXi AppTec Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products & medical devices | Health Technology |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd invests in companies located in the US. It targets the companies operating in the fields of consumer, financial services, healthcare and Technology. It provides financing for growth transactions. | Finance |
Gan & Lee Pharmaceuticals Co., Ltd.
 Gan & Lee Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes human therapeutics | Health Technology |
Life Science Holdings, Inc.
Life Science Holdings, Inc. Pharmaceuticals: OtherHealth Technology Manufactures white and private label cannabinoid products | Health Technology |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
General Atlantic LLC (China)
 General Atlantic LLC (China) Investment ManagersFinance Acts as an alternative investment manager | Finance |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Health Technology |
Wuxi Biologics (Cayman), Inc.
 Wuxi Biologics (Cayman), Inc. BiotechnologyHealth Technology Engages in discovery, development and manufacturing of biologics | Health Technology |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wuxi New Life Science Investment Ltd.
Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Wuxi Nextcode Holdings Ltd.
Wuxi Nextcode Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Boyu Capital Group Management Ltd. | |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Fujian Herui Gene Technology Co., Ltd.
 Fujian Herui Gene Technology Co., Ltd. BiotechnologyHealth Technology Engages in biotechnological services | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
Gushengtang Holdings Ltd.
 Gushengtang Holdings Ltd. Internet Software/ServicesTechnology Services Operate primary health care platform | Technology Services |
Hygeia Healthcare Holdings Co., Ltd.
 Hygeia Healthcare Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
